OpportunityTitle: Innovative Epidemiologic Approaches for Understanding Long-term Health Outcomes of HIV-exposed Uninfected (HEU) Populations (R61/R33 Clinical Trial Not Allowed)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Description: The purpose of this funding opportunity announcement (FOA) is to encourage the use of a phased research approach to generate information needed to develop interventions to reduce long-term effects of in utero exposure to antiretroviral therapy (ART) and/or HIV on health outcomes. This FOA will support two-phased research applications to (1) demonstrate the capacity to enroll sufficient numbers of HIV-exposed uninfected (HEU) infants, children, adolescents, and/or young adults in the United States and/or international settings with high HIV burden, and then, to (2) utilize the established cohort with innovative epidemiological approaches to conduct research.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV